{"id":"NCT01973205","sponsor":"Novartis","briefTitle":"Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine","officialTitle":"A Multi-center, Randomized, Double-blind, Parallel-group, Single-dose, Placebo-controlled Study Comparing the Efficacy and Safety of a Combination of Acetaminophen and Aspirin vs Placebo in the Acute Treatment of Migraine","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-10","primaryCompletion":"2014-07","completion":"2014-07","firstPosted":"2013-10-31","resultsPosted":"2015-06-11","lastUpdate":"2015-06-11"},"enrollment":900,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Acute Migraine"],"interventions":[{"type":"DRUG","name":"Acetaminophen 250 mg and Aspirin 250 mg","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Acetaminophen 250 mg and aspirin 250 mg","type":"EXPERIMENTAL"}],"summary":"The purpose of the study is to evaluate the efficacy and safety of acetaminophen and aspirin versus placebo in the acute treatment of migraine","primaryOutcome":{"measure":"Number of Subjects Who Are Pain Free at the 2-hour Assessment","timeFrame":"2 hours","effectByArm":[{"arm":"Placebo","deltaMin":69,"sd":null},{"arm":"Acetaminophen 250 mg and Aspirin 250 mg","deltaMin":90,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":19,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":415},"commonTop":[]}}